International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy

Journal of Clinical Oncology

Volumn 20, Issue 15, 2002, Pages 3206-3212

  Graefen, Markus ^a   Karakiewicz, Pierre I ^a   Cagiannos, Ilias ^a   Quinn, David I ^a   Henshall, Susan M ^a   Grygiel, John J ^a   Sutherland, Robert L ^a   Stricker, Phillip D ^a   Klein, Eric ^a   Kupelian, Patrick ^a   Skinner, Donald G ^a   Lieskovsky, Gary ^a   Bochner, Bernard ^a   Huland, Hartwig ^a   Hammerer, Peter G ^a   Haese, Alexander ^a   Erbersdobler, Andreas ^a   Eastham, James A ^a   De Kernion, Jean ^a   Cangiano, Thomas ^a   Schröder, Fritz H ^a   Wildhagen, Mark F ^a   Van der Kwast, Theo H ^a   Scardino, Peter T ^a   Kattan, Michael W ^a   more..

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE; PROSTATE SPECIFIC ANTIGEN;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER HORMONE THERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; PATIENT SELECTION; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK FACTORS; ROC CURVE; SURVIVAL ANALYSIS;

EID: 0036682051     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.12.019     Document Type: Article

References (13)

1. Assessing the generalizability of prognostic information
2. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer
3. Comparing tumor staging and grading systems: A case study and a review of the issues, using thymoma as a model
4. Evaluating the yield of medical tests
5. Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer
6. Artificial neural networks in the diagnosis and prognosis of prostate cancer: A pilot study
7. Early prostate-specific antigen relapse after radical retropubic prostatectomy: Prediction on the basis of preoperative and postoperative tumor characteristics
8. Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer
9. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer
10. Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer
11. Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer
12. Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer